Shield Therapeutics PLC (STX)
Industry Drug Manufacturers - Specialty & Generic
Sell
2.45p
Buy
2.70p
-0.087p (-3.38%)
Shield Therapeutics PLC is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.
Prices updated at 05 Jun 2025, 07:48 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Peter Hermann William Llewellyn-Davies
CEO
-
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
63
Head office
Northern Design Centre
Newcastle
United Kingdom
NE8 3DF
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Mr. Peter Hermann William Llewellyn-Davies Non-Executive Director, Vice Chairman | - | - | - | 0.06m | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| Miton Asset Management Limited | 16,779,605 | 1.2478 | - | - | 31 May 2025 | 1.61 |
| Premier Miton UK Smaller Companies | 16,779,605 | 1.2478 | - | - | 31 May 2025 | 1.61 |
| Miton UK Microcap | 12,333,531 | 0.89926 | - | - | 31 May 2025 | 1.18 |
| Intuitive Investments Group PLC | - | - | -781155 | - | 31 May 2025 | - |
| FIL Investment Services (UK) Ltd | - | - | -11880003 | - | 31 May 2025 | - |
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| 13 Feb 2025 | Purchase | Mr. Karl Anders Lundstrom | 3.70 | 21,275 | 585,000 | 0.06 | - |
Please note that past performance is not a reliable indicator of future returns.
